↓ Skip to main content

Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States

Overview of attention for article published in Clinical Infectious Diseases, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Citations

dimensions_citation
268 Dimensions

Readers on

mendeley
284 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States
Published in
Clinical Infectious Diseases, November 2012
DOI 10.1093/cid/cis942
Pubmed ID
Authors

Yohei Doi, Yoon Soo Park, Jesabel I. Rivera, Jennifer M. Adams-Haduch, Ameet Hingwe, Emilia M. Sordillo, James S. Lewis, Wanita J. Howard, Laura E. Johnson, Bruce Polsky, James H. Jorgensen, Sandra S. Richter, Kathleen A. Shutt, David L. Paterson

Abstract

Background. The occurrence of community-associated infections due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has been recognized as a major clinical problem in Europe and other regions. Methods. We conducted a prospective observational study to examine the occurrence of community-associated infections due to ESBL-producing E. coli at centers in the United States. Five academic and community hospitals and their affiliated clinics participated in this study in 2009 and 2010. Sites of acquisition of the organisms (community-associated or healthcare-associated), risk factors, and clinical outcome were investigated. Screening for the global epidemic sequence type (ST) 131 and determination of the ESBL types was conducted by polymerase chain reaction and sequencing. Results. Of the 291 patients infected or colonized with ESBL-producing E. coli as outpatients or within 48 hours of hospitalization, 107 (36.8%) had community-associated infection (81.5% of which represented urinary tract infection), while the remainder had healthcare-associated infection. Independent risk factors for healthcare-associated infection over community-associated infection were the presence of cardiovascular disease, chronic renal failure, dementia, solid organ malignancy, and hospitalization within the previous 12 months. Of the community-associated infections, 54.2% were caused by the globally epidemic ST131 strain, and 91.3% of the isolates produced CTX-M-type ESBL. Conclusions. A substantial portion of community-onset, ESBL-producing E. coli infections now occur among patients without discernible healthcare-associated risk factors in the United States. This epidemiologic shift has implications for the empiric management of community-associated infection when involvement of E. coli is suspected.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 284 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Argentina 1 <1%
Spain 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 277 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 49 17%
Student > Ph. D. Student 32 11%
Student > Master 31 11%
Other 27 10%
Student > Bachelor 26 9%
Other 68 24%
Unknown 51 18%
Readers by discipline Count As %
Medicine and Dentistry 101 36%
Agricultural and Biological Sciences 31 11%
Immunology and Microbiology 26 9%
Biochemistry, Genetics and Molecular Biology 19 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 2%
Other 32 11%
Unknown 68 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2020.
All research outputs
#1,918,880
of 25,374,647 outputs
Outputs from Clinical Infectious Diseases
#3,355
of 16,853 outputs
Outputs of similar age
#12,608
of 192,733 outputs
Outputs of similar age from Clinical Infectious Diseases
#18
of 146 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,853 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.7. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,733 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 146 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.